SCHEMBL19902141

SCHEMBL19902141

CCS(=O)(=O)N[C@H](Cc1ccccc1)C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.53
CYP2C19 P33261 1/20 0.53
CA12 O43570 2/20 0.50
CA9 Q16790 2/20 0.50
CA1 P00915 1/20 0.50
TSHR P16473 1/20 0.48
MMP2 P08253 5/20 0.48
MMP9 P14780 4/20 0.48
ADAMTS4 O75173 1/20 0.48
EPHX1 P07099 1/20 0.46
POLB P06746 2/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPT P10636 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA14 Q9ULX7 1/20 0.46
ITGB3 P05106 1/20 0.45
ITGA2B P08514 1/20 0.45
FCER2 P06734 2/20 0.45
MMP1 P03956 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16886917 1.00 CYP3A4 (0.53) CYP3A4CYP2C19CA12CA9CA1
SCHEMBL16886918 1.00 CYP3A4 (0.53) CYP3A4CYP2C19CA12CA9CA1
SCHEMBL10478603 0.88 ITGB3 (0.57) CYP3A4CYP2C19CA1TSHRMMP2
SCHEMBL29459566 0.87 MMP2 (0.61) MMP2MMP9ADAMTS4POLBALDH1A1
SCHEMBL16886884 0.86 CYP3A4 (0.57) CYP3A4CYP2C19CA12CA9CA1
SCHEMBL16886887 0.86 CYP3A4 (0.57) CYP3A4CYP2C19CA12CA9CA1
SCHEMBL5313228 0.86 CYP3A4 (0.57) CYP3A4CYP2C19CA12CA9CA1
SCHEMBL18198037 0.83 CYP3A4 (0.52) CYP3A4CYP2C19CA12CA9CA1
SCHEMBL18198008 0.83 CYP3A4 (0.52) CYP3A4CYP2C19CA12CA9CA1
SCHEMBL18198005 0.83 CYP3A4 (0.52) CYP3A4CYP2C19CA12CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9902726-B2 Pyridone-sulfone morphinan analogs as opioid receptor ligands PURDUE PHARMA L.P. (US) 2018-02-27 US disclosed